TRAIN-HEART Network

The TRAIN-HEART consortium, funded by the European Commission (2019-2023), is made up to train a league of 15 promising fellows that harness novel insights in the pathogenesis of ischemic heart failure, study the therapeutic potential of existing RNA therapeutics and improve its efficacy by the design of novel drug delivery systems.


People

TRAIN-HEART brings together leading academic teams and (biotech) companies covering various disciplines ranging from fundamental research to clinical pharmacology and gene therapy to drug delivery applications, have teamed up in the European Union.


Research Programme

The TRAIN-HEART network aims to gain viable insight in the pathogenesis of ischemic heart failure which will serve as a basis for drug discovery and drug delivery efforts that aim to therapeutically target specific molecules and mechanisms within cardiomyocytes for the treatment of ischemic heart failure.  


Contact

If you have any questions you can fill in the form or mail us directly: info@train-heart.eu.





News

World Heart Day today!

Since 2000, on the last Sunday in September we celebrate World Heart Day in order to raise global awareness of the importance of cardiovascular diseases and promote their control. The event arose as an initiative of the World Heart Federation and enjoys the patronage of the World Health Organization (WHO) and the United Nations Educational, Scientific, and Cultural Organization (UNESCO).

More

ESR Blog on Covid-19 period

Pandemic 101: lessons from COVID-19 to young researchers

More

Making the most of ‘omics data: Manuel Mayr, King’s College London

Nice workshop of Prof. Manuel Mayr, invited by the Alan Turing Institute on "Making the most of 'omics data"

More

Online X-omics Festival on 28 September 2020

The second edition of the X-omics festival “the future is now!” will take place online, on Monday September 28th 2020 from 09.30 – 14.00 CEST.

More

European Research & Innovation Days 2020

Bringing stakeholders together to shape future research and innovation policy.

More